Chenxi Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chenxi Hou has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Meng Zhang
College of Nuclear Science and Technology, Harbin Engineering University, Harbin 150001, China
2 shared publicationsCaishan Jiao
1 shared publication- Caishan Jiao
Harbin Engineering University
1 shared publication - Hai Dong
Key Laboratory of Material Chemistry for Energy Conversion and Storage, Ministry of Education, Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, School of Chemistry & Chemical Engineering, Huazhong University of Science & Technology, Luoyu Road 1037, Wuhan 430074, P. R. China
1 shared publication Haofan Fang
1 shared publication- Haofan Fang
College of Nuclear Science and Technology, Harbin Engineering University, Harbin 150001, China
1 shared publication
Latest Publications
- 12 July 2024
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 63 (29) , 12927-12937
Recovery of Uranium in a Carbonate Solution Using Methyltrioctylammonium Carbonate as the Extractant
- 12 July 2024
- Published by American Chemical Society (ACS) in Industrial & Engineering Chemistry Research
- Vol. 63 (29) , 12927-12937
Recovery of Uranium in a Carbonate Solution Using Methyltrioctylammonium Carbonate as the Extractant
- Open Access
- 28 September 2022
- Published by Elsevier in Nuclear Engineering and Technology
- Vol. 55 (1) , 63-70
Ultrasonic-assisted dissolution of U3O8 in carbonate medium
- 28 September 2022
- Published by Elsevier in Nuclear Engineering and Technology
- Vol. 55 (1) , 63-70
Open AccessUltrasonic-assisted dissolution of U3O8 in carbonate medium
- Open Access
- 1 May 2019
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 14, 3525-3532
A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
Background: Supramolecular vesicles are a novel class of nanocarriers that have great potential in biomedicine. Methods: A multifunctional supramolecular vesicle (CAAP5G) based on the complex of CAAP5 and galactose derivative (G) assembled via host-guest interaction was constructed. Results: Using Human embryonic kidney T (293T) cells as experimental models, the cytotoxic effects of CAAP5G was investigated to 0–50 μmol/L for 24 h. Notably, the CAAP5G vesicles revealed low-toxicity to 293T cells, it was critical to designing drug nano-carriers. Simultaneously, we have evaluated doxorubicin hydrochloride (DOX)-loaded CAAP5G vesicles anticancer efficiency, where DOX-loaded CAAP5G vesicles and free DOX incubated with Human hepatocellular carcinoma cancer cell (HpeG2 cells) and 293T cells for 24 h, 48 h, 72 h. It turned out that CAAP5G vesicles encapsulated anticancer drug (DOX) could decrease DOX side-effect on 293T cells and increase DOX anticancer efficiency. More importantly, the cysteamine as an adjuvant chemotherapy drug was released from CAAP5G vesicles in HepG2 cells where a higher GSH concentration exists. The adjuvant chemotherapy efficiency was evaluated, where free DOX and DOX-loaded CAAP5G vesicles incubated with DOX-resistance HepG2 cells (HepG2-ADR cells) for 24, 48, 72 h, respectively. Conclusion: The results revealed that the DOX encapsulated by CAAP5G vesicles could enhance the cytotoxicity of DOX and provide insights for designing advanced nano-carriers toward adjuvant chemotherapies.es.
- 1 May 2019
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 14, 3525-3532
Open AccessA multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
Background: Supramolecular vesicles are a novel class of nanocarriers that have great potential in biomedicine. Methods: A multifunctional supramolecular vesicle (CAAP5G) based on the complex of CAAP5 and galactose derivative (G) assembled via host-guest interaction was constructed. Results: Using Human embryonic kidney T (293T) cells as experimental models, the cytotoxic effects of CAAP5G was investigated to 0–50 μmol/L for 24 h. Notably, the CAAP5G vesicles revealed low-toxicity to 293T cells, it was critical to designing drug nano-carriers. Simultaneously, we have evaluated doxorubicin hydrochloride (DOX)-loaded CAAP5G vesicles anticancer efficiency, where DOX-loaded CAAP5G vesicles and free DOX incubated with Human hepatocellular carcinoma cancer cell (HpeG2 cells) and 293T cells for 24 h, 48 h, 72 h. It turned out that CAAP5G vesicles encapsulated anticancer drug (DOX) could decrease DOX side-effect on 293T cells and increase DOX anticancer efficiency. More importantly, the cysteamine as an adjuvant chemotherapy drug was released from CAAP5G vesicles in HepG2 cells where a higher GSH concentration exists. The adjuvant chemotherapy efficiency was evaluated, where free DOX and DOX-loaded CAAP5G vesicles incubated with DOX-resistance HepG2 cells (HepG2-ADR cells) for 24, 48, 72 h, respectively. Conclusion: The results revealed that the DOX encapsulated by CAAP5G vesicles could enhance the cytotoxicity of DOX and provide insights for designing advanced nano-carriers toward adjuvant chemotherapies.es.